Filing Details
- Accession Number:
- 0001225208-10-013418
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-19 13:00:00
- Reporting Period:
- 2010-05-17
- Filing Date:
- 2010-05-19
- Accepted Time:
- 2010-05-19 11:53:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 732485 | Genzyme Corp | GENZ | Biological Products, (No Disgnostic Substances) (2836) | 061047163 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1021041 | Peter Wirth | 500 Kendall Street Cambridge MA 02142 | Exec Vp,Legal & Corporate Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Genzyme Common Stock (Genz) | Acquisiton | 2010-05-17 | 48,216 | $26.50 | 55,072 | No | 4 | M | Direct | |
| Genzyme Common Stock (Genz) | Disposition | 2010-05-17 | 48,216 | $50.51 | 6,856 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Genzyme Common Stock (Genz) | Stock Option (right to buy) | Disposition | 2010-05-17 | 48,216 | $26.50 | 48,216 | $26.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2000-05-25 | 2010-05-25 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Genzyme Common Stock (Genz) | 148 | Indirect | By IRA |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 5, 2010.
- Includes 668 shares purchased from the issuer's Employee Stock Purchase Plan from April 2009 through April 2010.
Billionaire Hedge Funds
